PTPA and pancreatic ductal adenocarcinoma: Another most abundant serine/threonine phosphatases, PP2A, has been reported to show a promising utility, for example, combining PP2A activation with mTOR inhibition reduces c-Myc expression, thereby inhibiting proliferative signaling and inducing cell death in pancreatic ductal adenocarcinoma [65].